SRPT
Sarepta Therapeutics, Inc.
$110.5
Earnings Summary
Revenue | $467.17Mn |
Net Profits | $33.61Mn |
Net Profit Margins | 7.19% |
Highlights
Sarepta Therapeutics, Inc.’s revenue jumped 40.79% since last year same period to $467.17Mn in the Q3 2024. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated 28.72% jump in its revenue since last 3-months.
Sarepta Therapeutics, Inc.’s net profit jumped 182.1% since last year same period to $33.61Mn in the Q3 2024. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated 420.29% jump in its net profits since last 3-months.
Sarepta Therapeutics, Inc.’s net profit margin jumped 158.32% since last year same period to 7.19% in the Q3 2024. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated 304.2% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Sarepta Therapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.13 |
EPS Estimate Current Year | -0.13 |
Highlights
Sarepta Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.13 - a -1400% fall from last quarter’s estimates.
Sarepta Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.13.
Key Ratios
Key ratios of the Sarepta Therapeutics, Inc. post its Q3 2024 earnings
Earning Per Share (EPS) | 0.34 |
Highlights
Sarepta Therapeutics, Inc.’s earning per share (EPS) jumped 173.91% since last year same period to 0.34 in the Q3 2024. This indicates that the Sarepta Therapeutics, Inc. has generated 173.91% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-06 | -0.13 | 0.34 | 361.54% |
2024-05-01 | -0.07 | 0.37 | 628.57% |
2024-08-07 | 0.01 | 0.07 | 600% |
₹0 US Stocks a/c Opening Fee